Novavax Initiates Phase 1/2 Clinical Trial of Combination Vacc...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Sept. 8, 2021 /PRNewswire-AsiaNet/ -- -- First participants enrolled in Phase 1 clinical trial of combination NanoFlu(TM)/NVX–CoV2373 vaccine with Matrix-M(TM) adjuvant-- Phase 1/2 study will evaluate immunogenicity and safetyNovavax, Inc. (Nasdaq: NVAX), a biotechnology compa...
Authors: LATEST ASIANET NEWS RELEASES
